Shopping Cart 0
Cart Subtotal
USD 0

Norgine BV - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Norgine BV (Norgine) is a pharmaceutical company that offers medicinal products. The company develops drugs in the therapeutic areas of gastroenterology, incontinence, hepatology and critical and supportive care and pain management, among others. It offers the treatment of diseases related to gastrointestinal tract, gastric and hepatic conditions, critical and supportive care. Norgine offers drugs in the form of capsules, solutions, tablets, oral powder and medical device. The company also provides clinical supply services to organizations conducting clinical trials. It operates in the UK, France, Belgium, Germany and the Netherlands, among others. Norgine is headquartered in Amsterdam, the Netherlands.

Norgine BV-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Norgine BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Norgine BV, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Norgine BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Norgine BV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Norgine BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Norgine BV, Medical Equipment, Deal Details 10

Partnerships 10

Norgine Enters into Distribution Agreement with APHARM 10

Norgine Enters into Agreement with Noventure 11

Olympus America Enters into Distribution Agreement with Arc Medical Design 12

Norgine Expands its Distribution Agreement with Apharm for ZIVEREL 13

Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 14

PlasmaTech Biopharma Expands Licensing Agreement with Norgine for MuGard 15

Access Pharma Enters into Licensing Agreement with Norgine for MuGard 16

Acquisition 17

Norgine Acquires Merus Labs International 17

Norgine Acquires 70% stake in Arc Medical Design 19

Norgine BV-Key Competitors 20

Norgine BV-Key Employees 21

Norgine BV-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 24

Recent Developments 25

Strategy And Business Planning 25

Jul 20, 2018: Norgine opens its new German offices in Wettenberg 25

Jan 24, 2018: Norgine Opens New Headquarters in Amsterdam, Netherlands 26

Financial Announcements 27

Sep 12, 2018: Norgine releases H1 2018 results 27

Product News 28

Apr 21, 2018: New Data Show That High Quality Cleansing Improves Lesion Detection During Colonoscopy Compared to Adequate Cleansing 28

Other Significant Developments 29

Feb 26, 2018: Norgine's Performance in 2017 and Priorities for 2018 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Norgine BV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Norgine BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Norgine BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Norgine BV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Norgine BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Norgine BV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Norgine BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Norgine BV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Norgine BV, Medical Equipment, Key Facts 2

Norgine BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Norgine BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Norgine BV, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Norgine BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Norgine BV, Deals By Market, 2012 to YTD 2018 8

Norgine BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Norgine Enters into Distribution Agreement with APHARM 10

Norgine Enters into Agreement with Noventure 11

Olympus America Enters into Distribution Agreement with Arc Medical Design 12

Norgine Expands its Distribution Agreement with Apharm for ZIVEREL 13

Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 14

PlasmaTech Biopharma Expands Licensing Agreement with Norgine for MuGard 15

Access Pharma Enters into Licensing Agreement with Norgine for MuGard 16

Norgine Acquires Merus Labs International 17

Norgine Acquires 70% stake in Arc Medical Design 19

Norgine BV, Key Competitors 20

Norgine BV, Key Employees 21

Norgine BV, Other Locations 22

Norgine BV, Subsidiaries 22

Norgine BV, Joint Venture 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Norgine BV, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.